Valuation (10%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -20.25 | N/A |
PEG Ratio (TTM) | -0.35 | N/A |
P/S Ratio (TTM) | N/A | N/A |
P/B Ratio (TTM) | 2.21 | N/A |
P/FCF Ratio (TTM) | -54.86 | N/A |
Price to 5YR AVG Earnings Ratio | N/A | N/A |
Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -4.77% | N/A |
ROE (TTM) | -11.60% | N/A |
Net Profit Margin (TTM) | N/A | N/A |
ROIC 5YR AVG | N/A | N/A |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -236.83% | N/A | N/A |
Revenue | N/A | N/A | N/A |
Net Income | -24.06% | N/A | N/A |
Cash Flow | -33.54% | N/A | N/A |
Health (35%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.06 | N/A |
Quick Ratio (TTM) | 0.06 | N/A |
D/E Ratio (TTM) | 0.17 | N/A |
Interest Coverage (TTM) | -194.54 | N/A |
Piotroski F-Score | 2 | N/A |
Altman Z-Score | 5.16 | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | N/A | N/A |